Prevalence and incidence of hepatitis C virus infection among aboriginal young people who use drugs: Results from the Cedar Project

Open Medicine

Volumn 3, Issue 4, 2009, Pages

  Craib, Kevin J P ^a   Spittal, Patricia M ^a   Patel, Sheetal H ^a   Christian, Wayne M ^b   Moniruzzaman, A K M ^a   Pearce, Margo E ^a   Demerais, Lou ^c   Sherlock, Christopher ^a   Schechter, Martin T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Splats'in/Secwepemc Nation   (Canada)

^c Vancouver Native Health Society Clinic   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79151478517     PISSN: None     EISSN: 19112092     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Riben P, Bailey G, Hudson S, McColloch K, Dignan T, Martin D. Hepatitis C in Canada's first nations and Inuit populations: an unknown burden. Can J Public Health 2000;91(Suppl 1):S16-S18.
2. McMahon BJ, Hennessey TW, Christiansen C, Bruden D, Sullivan DG, Homan C, et al. Epidemiology and risk factors for hepatitis C in Alaska natives. Hepatology 2004;39(2):325-332.
3. Zou S, Tepper M, Giulivi A. Current status of hepatitis C in Canada. Can J Public Health 2000;91(Suppl 1):S10-S16.
4. Dawar M, Buxton J. Rate of reporting of hepatitis C infections in the Status Indian population of British Columbia, 2001. Paper presented at: 2nd Canadian Conference on Hepatitis C; 2004 Mar. 27-30; Vancouver, BC.
5. Gagné M. The role of dependency and colonialism in generating trauma in First Nations citizens. In: Danieli Y, ed., International handbook of multigenerational legacies of trauma. New York: Plenum Press; 1998. p. 355-372.
6. Miller JR. Shinwauk's vision. Toronto: University of Toronto Press; 1996.
7. Royal Commission on Aboriginal Peoples. Report of the Royal Commission on Aboriginal Peoples. Ottawa: The Commission; 1996.
8. Christian WM, Spittal PM. The Cedar Project: acknowledging the pain of our children. Lancet 2008;372(9644):1132-1133.
9. Vernon I. Killing us quietly: Native Americans and HIV/AIDS. Lincoln (NB): University of Nebraska Press; 2001.
10. O'Neil J. Research on HIV/AIDS in Aboriginal people: a background paper. Ottawa: Medical Services Branch, Health Canada; 1998. p. 4-41.
11. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans. 1998 (with 2000, 2002 and 2005 amendments). Available: www. pre.ethics.gc.ca/eng/policy-politique/tcps-eptc (accessed 2009 Aug 18).
12. Spittal PM, Craib KJP, Wood E, Laliberté N, Li K, Tyndall MW, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ 2002;166(7):894-899.
13. Patrick DM, Tyndall MW, Cornelisse PG, Li K, Sherlock CH, Rekart M, et al. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection. CMAJ 2001;165(7):889-895.
14. Hahn JA, Page-Shafer K, Lum PJ, Bourgois P, Stein E, Evans JL, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis 2002;186(11):1558-1564.
15. Thorpe L, Ouellet L, Hershow R, Bailey S, Williams IT, Williamson J, et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am J Epidemiol 2002;155(7):645-653.
16. Novelli L, Sherman S, Havens JR, Strathdee SA, Sapun M. Circumstances surrounding the first injection experience and their association with future syringe sharing behaviors in young urban injection drug users. Drug Alcohol Depend 2005;77(3):303-309.
17. Miller CL, Johnston C, Spittal PM, Li K, Laliberté N, Montaner JSG, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002;36(3):737-742.
18. Wood E, Tyndall MW, Spittal PM, Li K, Hogg RS, O'Shaughnessey MV, et al. Needle exchange and difficulty with needle access during an ongoing HIV epidemic. Int J Drug Policy 2002;13:95-102.
19. Fournier S, Crey E. Stolen from our embrace: the abduction of First Nations children and the restoration of Aboriginal communities. Vancouver: Douglas and McIntyre; 1997.
20. Adelson N. The embodiment of inequity: health disparities in Aboriginal Canada. Can J Public Health 2005;96(Suppl 2):S45-S61.
21. Aboriginal Healing Foundation. The healing has begun: an operational update from the Aboriginal Healing Foundation. Ottawa: The Foundation; 2002. Available: www.ahf.ca/publications/residential-schools-resources (accessed 2009 Sept 28).
22. Simoni JM, Sehgal S, Walters KL. Triangle of risk: urban American Indian women's sexual trauma, injection drug use, and HIV sexual risk behaviours. AIDS Behav 2004;8(1):33-45.
23. Simons R, Whitbeck L. Sexual abuse as precursor to prostitution and victimization among adolescent and adult homeless adult women. J Fam Issues 1991;12(3):361-379.
24. BC Aboriginal AIDS Task Force. The red road: pathways to wholeness. An Aboriginal strategy for HIV and AIDS in BC. Victoria (BC): Aboriginal Health Division, Ministry of Health; 1999. Available: www.hls.gov.bc.ca/publications/year/1999/red-road. pdf (accessed 2009 Aug 18).
25. Pearce ME, Christian WM, Patterson K, Norris K, Moniruzzaman A, Craib KJP, et al. The Cedar Project: historical trauma, sexual abuse and HIV risk among young Aboriginal people who use drugs in two Canadian cities. Soc Sci Med 2008;66(11):2185-2194.
26. Evan J, Hahn J, Page-Shafer K, Lum PJ, Stein ES, Davidson PJ, et al. Gender differences in sexual and injection risk behavior among young active injection drug users in San Francisco (the UFO Study). J Urban Health 2003;80(1):137-146.
27. Fox R, Currie S, Evans J, Wright TL, Tobler L, Phelps B, et al. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis 2005;41(2):177-186.
28. Miller C, Spittal PM, LaLiberte N, Li K, Tyndall MW, O'Shaughnessy MV, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr 2002;30(3):335-341.
29. Doherty MC, Garfein RS, Monterosso E, Brown D, Vlahov D. Correlates of HIV infection among young adult short-term injection drug users. AIDS 2000;14(6):717-726.
30. Fung K, Howe G. Methodological issues in case-control studies. III - The effect of joint misclassification of risk factors and confounding factors upon estimation and power. Int J Epidemiol 1984;13(3):366-370.